RAPID REPAIR Barrier Balancing Serum by Dermelect Cosmeceuticals

What is Bravecto For Small Dogs 9.9-22lbs (Orange) 3 Chews?

Bravecto For Small Dogs 9.9-22lbs (Orange) 3 Chews is a prescription-strength oral treatment designed to kill fleas and ticks in small dogs weighing between 9.9 and 22 pounds. Each chew contains fluralaner, an active ingredient that begins killing fleas within 2 hours and provides continuous protection for up to 12 weeks. This 3-pack offers 9 months of coverage, making it a convenient alternative to monthly treatments. Manufactured by Bravecto, a trusted name in pet parasiticide care, these palatable chews are formulated to be given orally with or without food.

Key features

• Long-Lasting Protection — Each chew delivers up to 12 weeks of flea and tick control.
• Fast-Acting Formula — Kills fleas within 2 hours and ticks within 12 hours of administration.
• Easy to Administer — Palatable chews are readily accepted by most dogs, no topical application needed.
• Broad Tick Coverage — Effective against black-legged, American dog, lone star, and brown dog ticks.
• Vet-Recommended Brand — Bravecto is widely prescribed by veterinarians for reliable parasite control.
• Convenient Dosing Schedule — Treat only once per quarter instead of monthly.
• Prescription-Strength — Contains 112.5 mg fluralaner per chew for optimal efficacy.

Who is Bravecto For Small Dogs 9.9-22lbs (Orange) 3 Chews for?

This product is ideal for owners of small dogs weighing 9.9 to 22 lbs who want reliable, long-term protection against fleas and ticks. It’s especially beneficial for pet parents looking to simplify parasite prevention with less frequent dosing. Dogs in high tick-risk areas or those with flea allergies will benefit from the rapid kill time and sustained coverage. A prescription is typically required, so veterinary consultation is recommended before use.

How does Bravecto For Small Dogs 9.9-22lbs (Orange) 3 Chews compare?

Compared to monthly oral treatments like NexGard or Simparica, Bravecto offers extended protection—three months per dose versus one—reducing the frequency of administration. Unlike topical solutions such as Frontline or Advantage, Bravecto is an oral chew, eliminating concerns about residue, bathing restrictions, or transfer to humans. While more expensive upfront than some monthly options, its longer duration can offer cost and convenience benefits over time. It is not suitable for dogs under 9.9 lbs or those with a history of neurological disorders.